Chabiotech Co.,Ltd. (KOSDAQ:085660)

Chabiotech Statistics

Total Valuation

Chabiotech has a market cap or net worth of KRW 609.55 billion. The enterprise value is 1.59 trillion.

Market Cap	609.55B
Enterprise Value	1.59T

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Chabiotech has 55.97 million shares outstanding. The number of shares has decreased by -0.92% in one year.

Current Share Class	55.97M
Shares Outstanding	55.97M
Shares Change (YoY)	-0.92%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	15.84%
Owned by Institutions (%)	12.14%
Float	41.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.55
PB Ratio	0.85
P/TBV Ratio	6.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-111.29
EV / Sales	1.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.44

Financial Position

The company has a current ratio of 0.65, with a Debt / Equity ratio of 1.17.

Current Ratio	0.65
Quick Ratio	0.56
Debt / Equity	1.17
Debt / EBITDA	n/a
Debt / FCF	-5.51
Interest Coverage	-1.37

Financial Efficiency

Return on equity (ROE) is -3.69% and return on invested capital (ROIC) is -2.80%.

Return on Equity (ROE)	-3.69%
Return on Assets (ROA)	-1.89%
Return on Invested Capital (ROIC)	-2.80%
Return on Capital Employed (ROCE)	-5.36%
Revenue Per Employee	3.82B
Profits Per Employee	-48.83M
Employee Count	292
Asset Turnover	0.56
Inventory Turnover	20.11

Taxes

In the past 12 months, Chabiotech has paid 10.60 billion in taxes.

Income Tax	10.60B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.84% in the last 52 weeks. The beta is 0.41, so Chabiotech's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-33.84%
50-Day Moving Average	10,539.66
200-Day Moving Average	13,372.37
Relative Strength Index (RSI)	52.45
Average Volume (20 Days)	393,154

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Chabiotech had revenue of KRW 1.12 trillion and -14.26 billion in losses. Loss per share was -255.20.

Revenue	1.12T
Gross Profit	296.83B
Operating Income	-59.92B
Pretax Income	-14.74B
Net Income	-14.26B
EBITDA	-9.82B
EBIT	-59.92B
Loss Per Share	-255.20

Balance Sheet

The company has 287.38 billion in cash and 837.10 billion in debt, giving a net cash position of -549.72 billion or -9,821.04 per share.

Cash & Cash Equivalents	287.38B
Total Debt	837.10B
Net Cash	-549.72B
Net Cash Per Share	-9,821.04
Equity (Book Value)	718.09B
Book Value Per Share	5,187.90
Working Capital	-377.15B

Cash Flow

In the last 12 months, operating cash flow was -88.26 billion and capital expenditures -63.79 billion, giving a free cash flow of -152.05 billion.

Operating Cash Flow	-88.26B
Capital Expenditures	-63.79B
Free Cash Flow	-152.05B
FCF Per Share	-2,716.43

Margins

Gross margin is 26.58%, with operating and profit margins of -5.37% and -1.28%.

Gross Margin	26.58%
Operating Margin	-5.37%
Pretax Margin	-1.32%
Profit Margin	-1.28%
EBITDA Margin	-0.88%
EBIT Margin	-5.37%
FCF Margin	n/a

Dividends & Yields

Chabiotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.92%
Shareholder Yield	n/a
Earnings Yield	-2.34%
FCF Yield	-24.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 2, 2014. It was a reverse split with a ratio of 0.7262.

Last Split Date	Jun 2, 2014
Split Type	Reverse
Split Ratio	0.7262

Scores

Chabiotech has an Altman Z-Score of 0.72 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.72
Piotroski F-Score	2